Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-21

Clinical Trial Update: Identification of Compound From Brinjal Peel Extract in the Treatment of Palmar Arsenical Keratosis and Bowen's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial investigating a compound from brinjal peel extract for palmar arsenical keratosis and Bowen's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Compound from brinjal peel extract

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Keratotic Nodular Size | Phase 2 | Status: UNKNOWN